Supply of Fully Automated Blood Testing Machines

The contract entails the procurement and delivery of two fully automated blood testing machines engineered for rapid diagnostic testing in clinical or field environments, adhering to precise technical specifications that ensure accuracy, reliability, and operational efficiency under demanding conditions. These systems must support seamless integration into existing healthcare workflows and be capable of delivering timely, high-quality results without requiring intensive manual intervention. The requirement is restricted to small businesses under a Total Small Business Set-Aside, as defined by the SBA and FAR 19.5, aligning with federal initiatives to promote small business participation in defense-related procurements. The NAICS code 334516 identifies the category as Medical Equipment and Supplies Manufacturing, underscoring the specialized nature of the technological solution being sought. The solicitation, issued by the Department of Defense through the W7NN Uspfo Activity Nh Arng, has a response deadline of July 7, 2026, and is structured as a subcontract, meaning the winning vendor may be engaged by a prime contractor to fulfill the requirement. Performance is expected to be fulfilled with the primary location designated by ZIP code 03301, though broader logistical details such as delivery timelines, training support, warranty provisions, and compliance with military or healthcare regulatory standards are not explicitly stated. All proposals must demonstrate not only technical capability but also the capacity to deliver and sustain these advanced diagnostic instruments in potentially resource-constrained or mobile settings, reflecting the operational priorities of the defense and public health infrastructure supported by this acquisition.